REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $342,790 | +31.2% | 3,362 | +17.0% | 0.20% | +41.0% |
Q1 2023 | $261,304 | +73.0% | 2,874 | -27.7% | 0.14% | +82.3% |
Q4 2022 | $151,010 | +65.9% | 3,975 | +10.3% | 0.08% | +119.4% |
Q3 2022 | $91,000 | -16.5% | 3,604 | +0.7% | 0.04% | -10.0% |
Q2 2022 | $109,000 | -38.1% | 3,579 | -33.3% | 0.04% | -49.4% |
Q1 2022 | $176,000 | +17.3% | 5,364 | -5.6% | 0.08% | +38.6% |
Q4 2021 | $150,000 | 0.0% | 5,684 | +282.5% | 0.06% | -13.6% |
Q3 2021 | $150,000 | -32.1% | 1,486 | -4.7% | 0.07% | -27.5% |
Q2 2021 | $221,000 | -12.6% | 1,560 | -38.5% | 0.09% | -15.0% |
Q1 2021 | $253,000 | -18.1% | 2,537 | +1.6% | 0.11% | -16.4% |
Q4 2020 | $309,000 | +67.9% | 2,498 | +32.0% | 0.13% | +32.0% |
Q3 2020 | $184,000 | -45.1% | 1,893 | -11.8% | 0.10% | -39.0% |
Q2 2020 | $335,000 | +33.5% | 2,146 | +23.5% | 0.16% | +54.4% |
Q1 2020 | $251,000 | -38.3% | 1,738 | -12.8% | 0.10% | +53.7% |
Q4 2019 | $407,000 | +63.5% | 1,992 | -35.8% | 0.07% | +34.0% |
Q3 2019 | $249,000 | -19.4% | 3,101 | -5.3% | 0.05% | -23.1% |
Q2 2019 | $309,000 | -17.8% | 3,273 | -25.5% | 0.06% | -91.9% |
Q1 2019 | $376,000 | +35.3% | 4,396 | -11.3% | 0.80% | +1566.7% |
Q4 2018 | $278,000 | -71.5% | 4,956 | -58.5% | 0.05% | -52.5% |
Q3 2018 | $976,000 | +36.3% | 11,939 | -41.7% | 0.10% | -84.0% |
Q2 2018 | $716,000 | +16.0% | 20,484 | -31.9% | 0.63% | +18.3% |
Q1 2018 | $617,000 | +56.6% | 30,088 | +116.2% | 0.54% | +8.3% |
Q4 2017 | $394,000 | -2.0% | 13,917 | +7.7% | 0.49% | +814.8% |
Q3 2017 | $402,000 | +8.1% | 12,925 | +10.1% | 0.05% | -3.6% |
Q2 2017 | $372,000 | +27.4% | 11,743 | -9.0% | 0.06% | +7.7% |
Q1 2017 | $292,000 | +14.5% | 12,909 | +10.6% | 0.05% | -31.6% |
Q4 2016 | $255,000 | – | 11,672 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |